EP2977057

ISOLATED RECOMBINANT HUMAN N-GLYCOSYLATED LYSOSOMAL ACID LIPASE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    9.9.2011
  • EP published:
    6.11.2019
  • EP application number:
    14200334.2
  • Max expiry date:
    8.9.2031
  • Title:
    ISOLATED RECOMBINANT HUMAN N-GLYCOSYLATED LYSOSOMAL ACID LIPASE

Timeline

Today
9.9.2011EP application
6.11.2019EP Publication

Owner

  • Name:
    Alexion Pharmaceuticals, Inc.
  • Address:
    121 Seaport Boulevard, 02210, Boston, MA, US

Inventor

  • Name:
    Quinn, Anthony
  • Address:
    Chestnut Hill, MA Massachusetts, US

Priority

  • Number:
    403011 P
  • Date:
    9.9.2010
  • Country:
    US
  • Number:
    456014 P
  • Date:
    29.10.2010
  • Country:
    US
  • Number:
    201161432372 P
  • Date:
    13.1.2011
  • Country:
    US
  • Number:
    PCT/US2011/033699
  • Date:
    23.4.2011
  • Country:
    WO

Classification

  • Categories:
    C12N 9/18, A61K 38/46, A61K 31/135, A61K 31/366, A61K 31/397, A61K 31/465, A61P 3/06

Upload documents